Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Outlook Therapeutics (OTLK) over the last 7 years, with Q3 2025 value amounting to -$1.6 million.

  • Outlook Therapeutics' Tax Provisions changed N/A to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.5 million, marking a year-over-year change of. This contributed to the annual value of -$1.6 million for FY2025, which is 5552246.43% down from last year.
  • According to the latest figures from Q3 2025, Outlook Therapeutics' Tax Provisions is -$1.6 million.
  • Over the past 5 years, Outlook Therapeutics' Tax Provisions peaked at $2800.0 during Q1 2025, and registered a low of -$1.6 million during Q3 2025.